BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10923058)

  • 1. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.
    Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K
    Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual task abilities as a possible preclinical marker of Alzheimer's disease in carriers of the E280A presenilin-1 mutation.
    MacPherson SE; Parra MA; Moreno S; Lopera F; Della Sala S
    J Int Neuropsychol Soc; 2012 Mar; 18(2):234-41. PubMed ID: 22133015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test].
    Tirado V; Muñoz C; Aguirre C; Pineda DA; Lopera F
    Rev Neurol; 2004 Aug 16-31; 39(4):322-6. PubMed ID: 15340889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation.
    Ardila A; Lopera F; Rosselli M; Moreno S; Madrigal L; Arango-Lasprilla JC; Arcos M; Murcia C; Arango-Viana JC; Ossa J; Goate A; Kosik KS
    Arch Clin Neuropsychol; 2000 Aug; 15(6):515-28. PubMed ID: 14590205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological features of familial Alzheimer's disease.
    Swearer JM; O'Donnell BF; Drachman DA; Woodward BM
    Ann Neurol; 1992 Nov; 32(5):687-94. PubMed ID: 1449250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
    Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
    Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
    Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
    Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene.
    Arango Lasprilla JC; Iglesias J; Lopera F
    Am J Alzheimers Dis Other Demen; 2003; 18(3):137-46. PubMed ID: 12811988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on mutation of exon 5 of presenilin-1 in Alzheimer's disease].
    Ma Q; Qian C; Liu Z; Lu X; Lin H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):349-52. PubMed ID: 10581340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients.
    Hom J; Turner MB; Risser R; Bonte FJ; Tintner R
    J Clin Exp Neuropsychol; 1994 Aug; 16(4):568-76. PubMed ID: 7962359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis.
    Hattori S; Sakuma K; Wakutani Y; Wada K; Shimoda M; Urakami K; Kowa H; Nakashima K
    Neurosci Lett; 2004 Sep; 368(3):319-22. PubMed ID: 15364419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.
    Taddei K; Fisher C; Laws SM; Martins G; Paton A; Clarnette RM; Chung C; Brooks WS; Hallmayer J; Miklossy J; Relkin N; St George-Hyslop PH; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(7):776-81. PubMed ID: 12192622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive changes in the preclinical phase of familial Alzheimer's disease.
    Arango-Lasprilla JC; Cuetos F; Valencia C; Uribe C; Lopera F
    J Clin Exp Neuropsychol; 2007 Nov; 29(8):892-900. PubMed ID: 17852592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.